Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era
โ Scribed by M. Susan Mandell
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 73 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20260
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hepatopulmonary syndrome (HPS) occurs when intrapulmonary vascular dilatation leads to abnormal arterial gas exchange in the setting of liver disease and/or portal hypertension. 1 Over the past 15 years, HPS has emerged as a relatively common complication of cirrhosis, occurring in 15 to 20% of case
The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an
The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End-Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post-LT chronic renal failure (CRF) and its effect on patien